you are here: Home News Oncology

Oncology

Concord Biotech: Strong grip on fermentation APIs stays
Gland Pharma: Does it still offer value after a strong run?
Ami Organics: Multiple growth catalysts taking shape
World Cancer Day 2023 | Precision oncology is not a cancer test or drug, it's an orientation: Dr Sewanti Limaye
Cancer therapy shifting from patient-fitting treatment to treatment-fitting patient model: Novartis India MD
Cipla: Sharp improvement in margins not likely to sustain
Another great quarter for Dr Reddy’s, but is it sustainable?
Blue Jet Healthcare files draft papers with SEBI to raise funds via IPO
Asia Healthcare Holdings raises $170 million from Singapore’s GIC
At Shivalik Rasayan, pharma comes up as a big growth lever
Glenmark Life Sciences IPO: Traction in complex APIs holds re-rating potential
Ideas for Profit | An agrichem small cap undergoing a pharmaceutical makeover
On track for growth; new centers ramping up quickly: Healthcare Global Ent
New plant in Haryana will focus on nephrology, to start by July: Poly Medicure
See EBITDA margins at 25% over 10 years: Glenmark CMD
Novartis acquires US pharma firm Selexys Pharmaceuticals
Aim to have 26 oncology centers by FY18: Healthcare Global
Biocon rallies 2% on Acacia Life's manufacturing unit buy
Sun Pharma's Ahmednagar plant comes under USFDA scanner
Dr Datsons Lab bags Rs 120cr order to produce cancer drugs
Shilpa Medicare up 10%, awaits USFDA nod for Raichur units
Revenue to grow at 5-10% in FY16-17: Shilpa Medicare
CCI clears Novartis-GSK pharma deal
Discovery IQ PET/CT - Excellent quality, zero compromise
Making cancer care in India economical

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Oncology

Concord Biotech: Strong grip on fermentation APIs stays

Gland Pharma: Does it still offer value after a strong run?

Ami Organics: Multiple growth catalysts taking shape

World Cancer Day 2023 | Precision oncology is not a cancer test or drug, it's an orientation: Dr Sewanti Limaye

Cancer therapy shifting from patient-fitting treatment to treatment-fitting patient model: Novartis India MD

Cipla: Sharp improvement in margins not likely to sustain

Another great quarter for Dr Reddy’s, but is it sustainable?

Blue Jet Healthcare files draft papers with SEBI to raise funds via IPO

Asia Healthcare Holdings raises $170 million from Singapore’s GIC

At Shivalik Rasayan, pharma comes up as a big growth lever

Glenmark Life Sciences IPO: Traction in complex APIs holds re-rating potential

Ideas for Profit | An agrichem small cap undergoing a pharmaceutical makeover

On track for growth; new centers ramping up quickly: Healthcare Global Ent

New plant in Haryana will focus on nephrology, to start by July: Poly Medicure

See EBITDA margins at 25% over 10 years: Glenmark CMD

Novartis acquires US pharma firm Selexys Pharmaceuticals

Aim to have 26 oncology centers by FY18: Healthcare Global

Biocon rallies 2% on Acacia Life's manufacturing unit buy

Sun Pharma's Ahmednagar plant comes under USFDA scanner

Dr Datsons Lab bags Rs 120cr order to produce cancer drugs

Shilpa Medicare up 10%, awaits USFDA nod for Raichur units

Revenue to grow at 5-10% in FY16-17: Shilpa Medicare

CCI clears Novartis-GSK pharma deal

Discovery IQ PET/CT - Excellent quality, zero compromise

Making cancer care in India economical